Raltegravir PK in Neonates—Modeling Rising and Declining PK Profiles of Newborns Exposed to Raltegravir In Utero
0 comments.
Click here to read/write comments.
Topics:
Certara is the leading drug development consultancy with solutions spanning the discovery, preclinical and clinical stages of drug development.
Phoenix NLME: The Modern Population PK/PD Modeling Tool for Today’s Scientists Phoenix NLMETM software is a population modeling and simulation solution for scientists with varying levels of experience—from the novice PK/PD scientists to the most advanced modelers. This comprehensive package includes integrated data preparation, modeling, and graphics tools with the same user interface that is used in […]
Read More